SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 9

Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy

Tolga AKSU
Tümer Erdem GÜLER
Kıvanç YALIN
Şükriye Ebru GÖLCÜK
Kazım Serhan ÖZCAN
Pages
707–712
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to review the clinical aspects of ESA procedure and provide some historical background

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM).
📊
Key Findings & Data:Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy.
💡
Conclusion & Impact:We aimed to review the clinical aspects of ESA procedure and provide some historical background
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM). Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy. Endocardial septal ablation (ESA) therapy was relatively new defined modality and outcomes of the procedure were not clearly elucidated yet. We aimed to review the clinical aspects of ESA procedure and provide some historical background

🔖

Cite This Article

AKSU, T., GÜLER, T. E., YALIN, K., GÖLCÜK, Ş. E., ÖZCAN, K. S. (2016). Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 9, 707–712. https://ajindex.com/articles/365512

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-91.
  2. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348: 295-303.
  3. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006; 114: 2232-9.
  4. Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 2006; 16: 1933-41. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79.
  5. Musat D, Sherrid MV. Pathophysiology of hypertrophic cardiomy- opathy determines its medical treatment. Anadolu Kardiyol Derg 2006; 6 Suppl 2: 9-17. Cleland WP. The surgical management of obstructive cardiomyopa- thy. J Cardiovasc Surg 1963; 4: 489-91.
  6. Morrow AG, Fogarty TJ, Hannah H 3rd, Braunwald E. Operative treatment in idiopathic hypertrophic subaortic stenosis. Tech- niques, and the results of preoperative and postoperative clinical and hemodynamic assessments. Circulation 1968; 37: 589-96.
  7. Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 1961; 154: 181-9.
  8. Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA. Ex- panding the indications for septal myectomy in patients with hy- pertrophic cardiomyopathy: results of operation in patients with latent obstruction. J Thorac Cardiovasc Surg 2012; 143: 303-9.
  9. Steggerda RC, Damman K, Balt JC, Liebregts M, ten Berg JM, van den Berg MP. Periprocedural complications and long-term out- come after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experi- ence. JACC Cardiovasc Interv 2014; 7: 1227-34. Lever HM. Selection of hypertrophic cardiomyopathy for myecto- my or alcohol septal ablation. Anadolu Kardiyol Derg 2006; Suppl 2: 27-30.
  10. Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H, et al.